Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome-Reference-Cited by-同舟云学术

Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome

Published:2021-01-15 Issue:2 Volume:13 Page:2982-3009
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Hao Huixin¹,Ma Siyuan¹,Zheng Cankun¹,Wang Qiancheng¹,Lin Hairuo¹,Chen Zhenhuan¹,Xie Jiahe¹,Chen Lin¹,Chen Kaitong¹,Wang Yuegang¹,Huang Xiaobo¹,Cao Shiping¹,Liao Wangjun²,Bin Jianping¹,Liao Yulin¹

Affiliation:

1. Department of Cardiology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Lab of Shock and Microcirculation, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

2. Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23;American Journal of Physiology-Renal Physiology;2024-04-01

2. Quantum key recovery attacks on tweakable Even–Mansour ciphers;Quantum Information Processing;2023-09-04

3. Pregnancy-induced physiological hypertrophic preconditioning attenuates pathological myocardial hypertrophy by activation of FoxO3a;Cellular and Molecular Life Sciences;2023-08-26

4. Renal fibrosis in type 2 cardiorenal syndrome: An update on mechanisms and therapeutic opportunities;Biomedicine & Pharmacotherapy;2023-08

5. Syringaresinol inhibits cardiorenal fibrosis through HSP90 in a cardiorenal syndrome type 2;Human & Experimental Toxicology;2023-03-24